A Mendelian Randomization Study of Infant Length and Type 2 Diabetes Mellitus Risk.

CONCLUSIONS: We validated that the shorter IL contributes no additional risk to T2DM. The sensitivity analysis and the MR-Egger regression analysis also provided adequate evidence the above result was not due to any heterogeneity or pleiotropic effect of IVs. PMID: 31553296 [PubMed - as supplied by publisher]
Source: Current Gene Therapy - Category: Genetics & Stem Cells Authors: Tags: Curr Gene Ther Source Type: research